You have requested access to member-only content.
2018 OPPS final rule: CMS finalizes massive cut to 340B drug program, introduces new modifiers for reporting
CMS is moving forward with its plan to drastically cut payments for drugs acquired through the 340B drug discount program, according to the 2018 OPPS final rule, released in November.
This is an excerpt from member-only content. Please log in or become a member.
Log in to access this content:
Unable to log in?
Click here to reset your password or unlock your account.
Forgot your username?
Contact customer care at customerservice@hcpro.com or call 800-650-6787, between 8 AM - 5 PM CT
Not a member? Join now!
Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.
For questions and support, please call customer service: 800-650-6787.
Try before you buy with our FREE samples!